Endocrine and metabolic effects of an oral contraceptive containing estetrol and drospirenone

To evaluate the effect on endocrine and metabolic parameters of a new combined oral contraceptive (COC) containing estetrol (E4) and drospirenone (DRSP).

Source: Contraception - January 8, 2021 Category: OBGYN Authors: Christine Klipping, Ingrid Duijkers, Marie Mawet, Catherine Maillard, Adriana Bastidas, Maud Jost, Jean-Michel Foidart Tags: Original Research Article Source Type: research